Abstract
Twenty-five patients with an acute exacerbation of chronic bronchitis completed a double-blind trial of amoxycillin 1.5 g v ampicillin 4 g daily. After treatment for one week there was no difference between the treatments in the rates of achieving mucoid sputum, reduction in sputum volume, improvement in peak expiratory flow rate, or duration of hospital stay. In the doses studied ampicillin and amoxycillin are effective drugs of about equal cost.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Acred P., Hunter P. A., Mizen L., Rolinson G. N. -amino-p-hydroxybenzylpenicillin (BRL 2333), a new broad-spectrum semisynthetic penicillin: in vivo evaluation. Antimicrob Agents Chemother (Bethesda) 1970;10:416–422. [PubMed] [Google Scholar]
- Grant I. W. Letter: Amoxycillin, talampicillin, and ampicillin. Br Med J. 1976 Jul 10;2(6027):106–106. doi: 10.1136/bmj.2.6027.106-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ingold A. Sputum and serum levels of amoxycillin in chronic bronchial infections. Br J Dis Chest. 1975 Jul;69:211–216. doi: 10.1016/0007-0971(75)90082-0. [DOI] [PubMed] [Google Scholar]
- Pines A., Nandi A. R., Raafat H., Rahman M. Amoxycillin and co-trimoxazole in acute purulent exacerbations of chronic bronchitis. Chemotherapy. 1977;23(1):58–64. doi: 10.1159/000221972. [DOI] [PubMed] [Google Scholar]